Mostrando 3 resultados de: 3
Filtros aplicados
Publisher
American Journal of Clinical Nutrition(1)
European Heart Journal(1)
Journal of the American College of Cardiology(1)
Área temáticas
Enfermedades(3)
Farmacología y terapéutica(2)
Fisiología humana(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Salud y seguridad personal(1)
Association of nut intake with risk factors, cardiovascular disease, and mortality in 16 countries from 5 continents: Analysis from the Prospective Urban and Rural Epidemiology (PURE) study
ReviewAbstract: Background: The association of nuts with cardiovascular disease and deaths has been investigated mosPalabras claves:Cardiovascular disease, Global Health, Mortality , nuts, prospective cohortAutores:Ahmed S.H., Alhabib K.F., Altuntas Y., Amma L.I.K.R., Anand S.S., Bangdiwala S.I., Basiak-Rasała A., Dagenais G.R., De Souza R.J., Dehghan M., DIaz R., Ismail R., Kelishadi R., Khatib R., Lear S.A., Mente A., Mohan V., PATRICIO LOPEZ -JARAMILLO, Poirier P., Rangarajan S., Rosengren A., Swaminathan S., Teo K.K., Wentzel-Viljoen E., Yeates K.E., Yusuf R., Yusuf S.Fuentes:googlescopusMortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease
ArticleAbstract: Background: The combination of 2.5 mg rivaroxaban twice daily and 100 mg aspirin once daily comparedPalabras claves:aspirin, Coronary artery disease, Mortality , Peripheral artery disease, rivaroxabanAutores:Anand S.S., Avezum A.J., Berkowitz S.D., Bhatt D.L., Bosch J.J., Branch K.R.H., Connolly S.J., Dagenais G.R., Eikelboom J.W., Felix Camilo, Fox K.A.A., Guzik T.J., Hart R.G., Maggioni A.P., Muehlhofer E., Sharma M., Shestakovska O., Yusuf S.Fuentes:googlescopusSimilar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin
ArticleAbstract: Objective : Recent European Guidelines for Diabetes, Pbkp_rediabetes and Cardiovascular Diseases intPalabras claves:Cardiovascular disease, GLP-1-based therapy, Metformin, Morbidity, MortalityAutores:Avezum A.J., Basile J.N., Colhoun H.M., Cushman W.C., Dagenais G.R., DIaz R., Dyal L., Ferrannini G., Gerstein H.C., Jansky P., Keltai M., Lakshmanan M., Lanas F.T., Leiter L.A., Mellbin L., Pais P., PATRICIO LOPEZ -JARAMILLO, PīrCrossed D Sign gs V., Pogosova N., Probstfield J.L., Raubenheimer P.J., Riddle M.C., Rydén L.E., Shaw J.E., Sheu W.H.H.Fuentes:googlescopus